Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TARS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 249 institutions reported holding TARS, with 47.3 million shares worth $3.0 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 3,856,137 | $243M | INCREASED |
| Deep Track Capital | 3,666,768 | $231M | INCREASED |
| Rtw Investments | 3,357,059 | $211M | INCREASED |
| Janus Henderson (Jupiter Topco) | 2,808,796 | $177M | INCREASED |
| Paradigm Biocapital Advisors | 2,775,649 | $175M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Neera Clase (Chief Commercial Officer) | AWARD | 6,678 | 2026-11-03 | |
| Neera Clase (Chief Commercial Officer) | AWARD | 10,587 | $769K | 2026-11-03 |
| William J Link PHD (Director) | EXERCISE | 201 | 2026-09-15 | |
| William J Link PHD (Director) | SELL | 66 | $5K | 2026-09-15 |
| William J Link PHD (Director) | SELL | 759 | $60K | 2026-09-15 |
Full institutional holdings, insider history, and congressional trades for Tarsus Pharmaceuticals, Inc. Common Stock on SentiSense.